Literature DB >> 19098121

Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling.

Eric Gutknecht1, Ilse Van der Linden, Kristof Van Kolen, Kim F C Verhoeven, Georges Vauquelin, Frank M Dautzenberg.   

Abstract

The molecular mechanisms governing calcium signal transduction of corticotropin-releasing factor (CRF) receptors CRF(1) and CRF(2(a)) stably expressed in human embryonic kidney (HEK) 293 cells were investigated. Calcium signaling strictly depended on intracellular calcium sources, and this is the first study to establish a prominent contribution of the three major G-protein families to CRF receptor-mediated calcium signaling. Overexpression of Galpha(q/11) and Galpha(16) led to leftward shifts of the agonist concentration-response curves. Blockade of Galpha(q/11) proteins by the small interfering RNA (siRNA) technology partially reduced agonist-mediated calcium responses in CRF(1)- and CRF(2(a))-expressing HEK293 cells, thereby proving a contribution of the G(q) protein family. A small but significant inhibition of calcium signaling was recorded by pharmacological inhibition of G(i/o) proteins with pertussis toxin treatment. This effect was mediated by direct binding of Gbetagamma subunits to phospholipase C. G(i/o) inhibition also elevated cAMP responses in CRF receptor-overexpressing HEK293 cells and in Y79 retinoblastoma cells endogenously expressing human CRF(1) and CRF(2(a)) receptors, thereby demonstrating natural coupling of G(i) proteins to both CRF receptors. The strongest reduction of CRF receptor-mediated calcium mobilization was noted when blocking the G(s) signaling protein either by cholera toxin or by siRNA. It is noteworthy that simultaneous inhibition of two G-proteins shed light on the additive effects of G(s) and G(q) on the calcium signaling and, hence, that they act in parallel. On the other hand, G(i) coupling required prior G(s) activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19098121     DOI: 10.1124/mol.108.050427

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  25 in total

1.  The Pseudo signal peptide of the corticotropin-releasing factor receptor type 2A prevents receptor oligomerization.

Authors:  Anke Teichmann; Claudia Rutz; Annika Kreuchwig; Gerd Krause; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

2.  The pseudo signal peptide of the corticotropin-releasing factor receptor type 2a decreases receptor expression and prevents Gi-mediated inhibition of adenylyl cyclase activity.

Authors:  Katharina Schulz; Claudia Rutz; Carolin Westendorf; Ingrid Ridelis; Susanne Vogelbein; Jens Furkert; Antje Schmidt; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

3.  Urocortin 3 elevates cytosolic calcium in nucleus ambiguus neurons.

Authors:  G Cristina Brailoiu; Elena Deliu; Andrei A Tica; Vineet C Chitravanshi; Eugen Brailoiu
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

4.  Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons.

Authors:  Christopher M Stern; John Meitzen; Paul G Mermelstein
Journal:  Eur J Neurosci       Date:  2011-08-08       Impact factor: 3.386

Review 5.  The corticotropin releasing factor system in cancer: expression and pathophysiological implications.

Authors:  Athina Kaprara; Kalliopi Pazaitou-Panayiotou; Alexandros Kortsaris; Ekaterini Chatzaki
Journal:  Cell Mol Life Sci       Date:  2010-02-09       Impact factor: 9.261

6.  P/Q-type voltage-gated calcium channels mediate the ethanol and CRF sensitivity of central amygdala GABAergic synapses.

Authors:  F P Varodayan; M L Logrip; M Roberto
Journal:  Neuropharmacology       Date:  2017-07-19       Impact factor: 5.250

Review 7.  Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications.

Authors:  M Larauche; C Kiank; Y Tache
Journal:  J Physiol Pharmacol       Date:  2009-12       Impact factor: 3.011

Review 8.  Role of CRF receptor signaling in stress vulnerability, anxiety, and depression.

Authors:  Richard L Hauger; Victoria Risbrough; Robert H Oakley; J Alberto Olivares-Reyes; Frank M Dautzenberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

9.  Dopamine D2 receptor desensitization by dopamine or corticotropin releasing factor in ventral tegmental area neurons is associated with increased glutamate release.

Authors:  Sudarat Nimitvilai; Melissa Herman; Chang You; Devinder S Arora; Maureen A McElvain; Marisa Roberto; Mark S Brodie
Journal:  Neuropharmacology       Date:  2014-03-19       Impact factor: 5.250

Review 10.  Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors.

Authors:  Cornelia Kiank; Yvette Taché; Muriel Larauche
Journal:  Brain Behav Immun       Date:  2009-08-19       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.